Celldex Therapeutics (CLDX) CEO pay: $4.8M actually paid in FY2025
$CLDX · Celldex Therapeutics, Inc.Data through FY2025 — latest proxy filed 2026-04-29, checked for new filings 2026-08-21. Every number links to its source.
1.2× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2020 | Same, peer group since FY2020 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $5.4M | $4.8M | $1.7M | $155.00 | $201.00 | -$258.8M |
| 2024 | $9.2M | $75,804 | $98,029 | $1133.00 | $173.00 | -$157.9M |
| 2023 | $8.4M | $3.7M | $1.5M | $1778.00 | $159.00 | -$141.4M |
| 2022 | $5.4M | $10.1M | $3.6M | $1999.00 | $153.00 | -$112.3M |
| 2021 | $6.0M | $13.9M | $5.1M | $1733.00 | $137.00 | -$70.5M |
| 2020 | $3.0M | $6.4M | $2.7M | $786.00 | $111.00 | -$59.8M |
Frequently asked
How much did the CLDX CEO make in 2025?
$4,834,841 in Compensation Actually Paid (CAP) as Celldex Therapeutics, Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-29.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on CLDX: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary